Thyroid disease

Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

ThyroidPublished Systematic review and meta-analysis of randomised trials

Pooled result · TSH in patients without THRTResult — go to the resultSMD −0.21 CI −0.43 to −0.02

Authors' conclusion

In people with HT without THRT, selenium was effective and safe in lowering TSH, TPOAb, and MDA levels. Indications for lowering TPOAb were found independent of THRT.

Study context

Population
Patients with Hashimoto thyroiditis (HT), with or without thyroid hormone replacement therapy (THRT); databases searched from inception to January 202335 studies
Comparison
Selenium supplementation vs control
Outcome
TSH in patients without THRT
Methodological detailsCochrane RoB 2 risk-of-bias assessment, Grading of Recommendations Assessment, Development, and Evaluation (GRADE) certainty rating, 687 records screened, Overall certainty of evidence moderate (GRADE)
  • Cochrane RoB 2 risk-of-bias assessment
  • GRADE certainty rating
  • 687 records screened
  • Overall certainty of evidence moderate (GRADE)

Pooled result

As reported in the abstract

SMD

−0.21

CI −0.43 to −0.02

Seleniumvs Control
SMD −0.21 (CI −0.43 to −0.02)

Further pooled results

TPOAb (patients with and without THRT)

TPOAb decreased, SMD
−0.96 (−1.36 to −0.56) (CI)
  • 29 cohorts; 2358 participants; I2 = 90%

Malondialdehyde (MDA) (patients with and without THRT)

MDA decreased, SMD
−1.16 (−2.29 to −0.02) (CI)
  • 3 cohorts; 248 participants; I2 = 85%

fT4, T4, fT3, T3, TGAb, thyroid volume, IL-2 and IL-10

No significant changes in fT4, T4, fT3, T3, TGAb, thyroid volume, IL-2 and IL-10

Safety

OutcomeOR (CI)
Adverse effects0.89 (0.46–1.75)
  • Adverse effects: 16 cohorts; 1339 participants; I2 = 0%; comparable between groups

Original publication

Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Thyroid. Published 20 January 2024. doi:10.1089/thy.2023.0556

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.